Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

818 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Recruiting

Phase III Trial of Camrelizumab+Apatinib+Eribulin vs. Physician's Choice Chemotherapy in Advanced Triple-Negative Breast Cancer

NCT06889688

Conditions
Breast Cancer Stage IV, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Sun Yat-sen Memorial Hospital Guangzhou, Guangdong, China
  • The Affiliated Hospital of Guizhou Medical University Guiyang, Guizhou, China
  • Wuhan Union Hospital of China Wuhan, Hubei, China
  • Yichang Central People's Hospital Yichang, Hubei, China
View Trial Details
Recruiting

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

NCT06586957

Conditions
Adnexal Diseases, Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, +62 more
Locations
  • University of Arkansas Medical School Little Rock, Arkansas, United States
  • University of California - Los Angeles Los Angeles, California, United States
  • UCSF San Francisco, California, United States
  • SCRI at HealthOne Denver, Colorado, United States
View all 19 locations
View Trial Details
Recruiting

A Study of Tetrathiomolybdate (TM) Plus Capecitabine

NCT06134375

Conditions
Breast Diseases, Breast Neoplasms, Neoplasm, Residual, +10 more
Locations
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
  • NYU Langone perimutter Cancer Center New York, United States
View Trial Details
Recruiting

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

NCT06270706

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced or Metastatic Solid Tumor, +64 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • South Texas Accelerated Research Therapeutics (START) Grand Rapids, Michigan, United States
  • NEXT Austin Austin, Texas, United States
View Trial Details

Related conditions